Skip to main content
AN

Attune Neurosciences

Attune Neurosciences develops a non-invasive medical device that utilizes low-intensity focused ultrasound to precisely target and modulate activity in the deep brain. This technology aims to improve treatment outcomes for chronic pain and various psychiatric and neurological conditions by addressing the limitations of current therapeutic options.

Menlo Park, United StatesFounded 201920700+ followers
Updated 4 months ago

Funding

$3.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current treatments for chronic pain, psychiatric, and neurological conditions often fall short, with medications proving inadequate long-term and advanced interventions like deep brain stimulation carrying significant side effects. Millions of patients experience untreated or unresponsive chronic pain under the current standard of care.

Solution

Attune Neurosciences is developing a non-invasive, wearable medical device that uses low-intensity focused ultrasound to precisely target and modulate activity in deep brain structures. This approach aims to improve treatment outcomes for a range of conditions, offering a potentially more effective and sustainable solution than existing options. The device is designed to target the root of the disease by modulating specific activity in the deep brain, addressing the limitations of current pharmaceutical and invasive treatments. Clinical trials are underway to demonstrate the safety and efficacy of the technology in treating conditions such as sleep disorders, depression, pain, movement disorders, and tinnitus.

Target Audience

The primary target audience includes individuals suffering from chronic pain, sleep disorders, depression, movement disorders, and tinnitus, as well as clinical researchers and healthcare providers seeking innovative treatment options.

Features

  • Non-invasive neuromodulation using low-intensity focused ultrasound
  • Precise targeting of deep brain structures
  • Wearable device for convenient application
  • Investigational device with ongoing clinical trials for various conditions
  • Ultrasound stimulation parameters within safety limits determined by AIUM and ITRUSST
This profile is AI-generated and may contain inaccuracies.